Lataa...
CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Mutations in CCAAT/enhancer binding protein α (CEBPA) occur in 5–10% of cases of acute myeloid leukemia. CEBPA-double-mutated cases usually bear biallelic N- and C-terminal mutations and are associated with a favorable clinical outcome. Identification of CEBPA mutants is challenging because of the v...
Tallennettuna:
| Julkaisussa: | Haematologica |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ferrata Storti Foundation
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5394975/ https://ncbi.nlm.nih.gov/pubmed/28250006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.151910 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|